2021 | A multicentre, randomised, open-label, parallel-group Phase 2b study of belotecan versus topotecan for recurrent ovarian cancer
| BRITISH JOURNAL OF CANCER |
2007 | A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status
| BRITISH JOURNAL OF CANCER |
2006 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens
| BRITISH JOURNAL OF CANCER |
2014 | A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer.
| BRITISH JOURNAL OF CANCER |
2021 | A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer
| BRITISH JOURNAL OF CANCER |
2012 | Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis
| BRITISH JOURNAL OF CANCER |
2018 | Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: An analysis of the phase 3 REACH study | BRITISH JOURNAL OF CANCER |
2017 | ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer | BRITISH JOURNAL OF CANCER |
2014 | Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients.
| BRITISH JOURNAL OF CANCER |
2021 | APC loss induces Warburg effect via increased PKM2 transcription in colorectal cancer
| BRITISH JOURNAL OF CANCER |
2023 | Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer
| BRITISH JOURNAL OF CANCER |
2020 | Association between the National Cancer Screening Programme (NSCP) for gastric cancer and oesophageal cancer mortality
| BRITISH JOURNAL OF CANCER |
2018 | Bcl-2-dependent synthetic lethal interaction of the IDF-11774 with the V0 subunit C of vacuolar ATPase (ATP6V0C) in colorectal cancer | British Journal of Cancer |
2021 | Body mass index and absolute lymphocyte count predict disease-free survival in Korean breast cancer patients
| BRITISH JOURNAL OF CANCER |
2023 | Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program | BRITISH JOURNAL OF CANCER |
2013 | Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes
| BRITISH JOURNAL OF CANCER |
1999 | Deletion mapping of chromosome 16q in hepatocellular carcinoma
| Br J Cancer |
2009 | DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers
| BRITISH JOURNAL OF CANCER |
2015 | Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea
| BRITISH JOURNAL OF CANCER |
2016 | Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers | BRITISH JOURNAL OF CANCER |
2018 | Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: Pooled analyses after long-term follow-up in KEYNOTE-012 | BRITISH JOURNAL OF CANCER |
2008 | ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
| BRITISH JOURNAL OF CANCER |
2013 | Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis
| BRITISH JOURNAL OF CANCER |
2001 | Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability
| BRITISH JOURNAL OF CANCER |
2014 | First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.
| BRITISH JOURNAL OF CANCER |
2023 | Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer | BRITISH JOURNAL OF CANCER |
2023 | Genomic and evolutionary characteristics of metastatic gastric cancer by routes
| BRITISH JOURNAL OF CANCER |
2012 | Genomic Grade Index predicts postoperative clinical outcome of GIST
| BRITISH JOURNAL OF CANCER |
2000 | Germline mutation of the STK 11 gene in Korean Peutz-Jegher syndrome patients
| British Journal of Cancer |
2007 | Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease
| BRITISH JOURNAL OF CANCER |
2020 | Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma
| BRITISH JOURNAL OF CANCER |
2017 | Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo | BRITISH JOURNAL OF CANCER |
2017 | Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma
| BRITISH JOURNAL OF CANCER |
2014 | Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II–III breast cancer? A multicentre retrospective study (KROG 12-05) | BRITISH JOURNAL OF CANCER |
2020 | Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response
| BRITISH JOURNAL OF CANCER |
2020 | Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck
| BRITISH JOURNAL OF CANCER |
2018 | Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma | BRITISH JOURNAL OF CANCER |
2020 | Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
| BRITISH JOURNAL OF CANCER |
2018 | Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer | BRITISH JOURNAL OF CANCER |
2021 | Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
| BRITISH JOURNAL OF CANCER |
2021 | Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer
| BRITISH JOURNAL OF CANCER |
2023 | Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial
| BRITISH JOURNAL OF CANCER |
2018 | Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology) | BRITISH JOURNAL OF CANCER |
2008 | Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer
| BRITISH JOURNAL OF CANCER |